Barrett Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BBA
Barrett Asset Management's ALXN Position: Q3 2017 in Review
Barrett Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2017, closing a stake of 100 shares — an estimated $12K sold.
Barrett Asset Management first reported a position in ALXN in Q1 2016 and held it in 6 quarters. The position peaked at $13K in Q1 2016. 595 funds tracked by Wall St. Rank hold ALXN as of Q3 2017.
- Barrett Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
- Barrett Asset Management sold 100 Alexion Pharmaceuticals shares in Q3 2017, an estimated $12K.
- Barrett Asset Management first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 6 quarters.
- Barrett Asset Management's Alexion Pharmaceuticals position peaked at $13K in Q1 2016.
- 595 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2017.
Based on Barrett Asset Management's 13F filing for Q3 2017, filed 8 Nov 2017.